Lazard Asset Management’s Heron Therapeutics HRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,815
| Closed | -$30K | – | 2397 |
|
|
2025
Q1 | $30K | Buy |
+13,815
| New | +$30K | ﹤0.01% | 2077 |
|
|
2024
Q3 | – | Sell |
-98,182
| Closed | -$343K | – | 2348 |
|
|
2024
Q2 | $343K | Buy |
+98,182
| New | +$343K | ﹤0.01% | 1361 |
|
|
2020
Q4 | – | Sell |
-4,180
| Closed | -$61K | – | 1900 |
|
|
2020
Q3 | $61K | Sell |
4,180
-1,285
| -24% | -$18.8K | ﹤0.01% | 1124 |
|
|
2020
Q2 | $80K | Buy |
5,465
+1,762
| +48% | +$25.8K | ﹤0.01% | 1074 |
|
|
2020
Q1 | $43K | Buy |
+3,703
| New | +$43K | ﹤0.01% | 1231 |
|
|
2018
Q3 | – | Sell |
-36,520
| Closed | -$1.42M | – | 1079 |
|
|
2018
Q2 | $1.42M | Buy |
+36,520
| New | +$1.42M | ﹤0.01% | 698 |
|